Strategies differ depending on whether youre dealing with diarrhea, constipation, or both
Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)
I remember we were very, very intrigued by what youre up to and so its its just such a pleasure to really become your friend over the years that weve been collaborating together

Try the BMI Calculator Table of contents The complete list: every GLP-1 receptor agonist by generic and brand name What most articles get wrong about GLP-1 drug classification Pure GLP-1 agonists vs dual agonists: why the distinction matters The brand name confusion problem: why semaglutide has three names Compounded GLP-1 medications: naming conventions and legal status The FormBlends Drug Name Classification System Discontinued and pipeline GLP-1 medications Generic availability timeline: when patents expire How to identify which GLP-1 medication you're taking The decision tree: matching drug names to your treatment goal FAQ Sources The complete list: every GLP-1 receptor agonist by generic and brand name The table below includes every FDA-approved GLP-1 receptor agonist and dual agonist as of April 2026, organized by approval date

Multilevel approach of a 1-year program of dietary and exercise interventions on bone mineral content and density in metabolic syndrome-the RESOLVE randomized controlled trial